Response of the aroma fraction in sherry wines subjected to accelerated biological aging.

The effect of an acceleration assay, carried out with a periodic aeration and an increased surface/volume ratio, on various aroma compounds of "fino" Sherry wines aging under a veil of a pure culture of Saccharomyces cerevisiae race capensis G1 flor film yeast was studied. The results were subjected to multifactor analysis of variance, and the compounds simultaneously depending on acceleration conditions and aging time at p < 0.01 were subjected to principal component analysis. The first component, accounting for 86.14% of the overall variance, was mainly defined by acetaldehyde and its derivatives 1,1-diethoxyethane and acetoin. These compounds reached higher concentrations in accelerated aging wines in a shorter time than they did in control wines, and no browning problems were detected. Taking into account that these compounds can be used as indicators for biological aging of "fino" Sherry wines, the acceleration condition assayed can be applied to shorten the time of this process.

[Recurrent syncope in patients with sick sinus syndrome carrying a permanent pacemaker]. / Síncopes recurrentes en pacientes con enfermedad del nodo sinusal portadores de marcapasos definitivo.

BACKGROUND: It is clear that permanent cardiac pacing in patients with sick sinus syndrome is effective. In spite of a normal pacemaker function, syncope may occur. Causes often remain unknown. The objective of this study was to review our current experience with these patients to identify predictors and etiologies of these symptoms. METHOD AND RESULTS: We studied 153 patients who received atrial, ventricular and dual-chamber pacemakers for sick sinus syndrome. During a median follow-up of 57.6 months (1-177 months), actuarial incidence of syncope or near syncope was 4.5% at 1 year, 9% at 5 years and 13% at 10 years. Causes were related with autonomic insufficiency (45%), pacemaker/lead malfunction (30%), pacemaker syndrome (10%) and conduction disturbances in patients with AAI pacemakers (10%). In only one patient (5%) syncope remained unexplained. Preimplant predictors for syncope were gender (male) and age (< 70 years old). CONCLUSIONS: 1) Syncopes in paced patients with sick sinus syndrome have multiple etiologies and may be multifactorial; 2) Autonomic dysfunction and "oversensing" in troubleshooting of implanted cardiac pacemakers could provide an explanation for recurrent syndrome in over 70% of these patients; 3) A better evaluation of neurogenic syncope may be necessary before pacemakers are implanted, to prevent recurrent syncope.